Clinical benefit with SGLT2 inhibitor in diabetes patients with HF independent of ejection fraction

Clinical benefit with SGLT inhibitor in diabetes patients with HF independent of ejection fraction
Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Register

We're glad to see you're enjoying PACE-CME…
but how about a more personalized experience?

Register for free